Key references: Nonresponse to initial pharmacotherapy for panic disorder in adults and young people

  • Baldwin DS, Anderson IM, Nutt DJ, Allgulander C, Bandelow B, den Boer JA, et al. Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology. J Psychopharmacol 2014;28(5):403–39. https://www.ncbi.nlm.nih.gov/pubmed/24713617
  • Bandelow B, Reitt M, Rover C, Michaelis S, Gorlich Y, Wedekind D. Efficacy of treatments for anxiety disorders: a meta-analysis. Int Clin Psychopharmacol 2015;30(4):183–92. https://www.ncbi.nlm.nih.gov/pubmed/25932596
  • Breilmann J, Girlanda F, Guaiana G, Barbui C, Cipriani A, Castellazzi M, et al. Benzodiazepines versus placebo for panic disorder in adults. Cochrane Database Syst Rev 2019;3:CD010677. https://www.ncbi.nlm.nih.gov/pubmed/30921478
  • Freire RC, Amrein R, Mochcovitch MD, Dias GP, Machado S, Versiani M, et al. A 6-year posttreatment follow-up of panic disorder patients: treatment with clonazepam predicts lower recurrence than treatment with paroxetine. J Clin Psychopharmacol 2017;37(4):429–34. https://www.ncbi.nlm.nih.gov/pubmed/28609307
  • Katzman MA, Bleau P, Blier P, Chokka P, Kjernisted K, Van Ameringen M, et al. Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders. BMC Psychiatry 2014;14 Suppl 1:S1. https://www.ncbi.nlm.nih.gov/pubmed/25081580
  • National Institute for Health and Care Excellence (NICE). Generalised anxiety disorder and panic disorder in adults: management [CG113]. London: NICE; 2011 (updated 2019). https://www.nice.org.uk/guidance/CG113
  • Patterson B, Van , Ameringen M. Augmentation strategies for treatment-resistant anxiety disorders: a systematic review and meta-analysis. Depress Anxiety 2016;33(8):728–36. https://www.ncbi.nlm.nih.gov/pubmed/27175543
  • Quagliato LA, Freire RC, Nardi AE. Risks and benefits of medications for panic disorder: a comparison of SSRIs and benzodiazepines. Expert Opin Drug Saf 2018;17(3):315–24. https://www.ncbi.nlm.nih.gov/pubmed/29357714
  • Uguz F, Sahingoz M, Gungor B, Askin R. Low-dose imipramine for treatment of panic disorder during pregnancy: a retrospective chart review. J Clin Psychopharmacol 2014;34(4):513–5. https://www.ncbi.nlm.nih.gov/pubmed/24875076